Market Overview

NPS Pharma Says Gattex Meeting October 16th

NPS Pharmaceuticals (NASDAQ: NPSP) today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that its New Drug Application (NDA) for Gattex® (teduglutide) will be discussed at the Gastrointestinal Drugs Advisory Committee meeting scheduled for October 16, 2012. The Prescription Drug User Fee Act (PDUFA) date for completion of review by the FDA is December 30, 2012.

Posted-In: News FDA

 

Most Popular

Related Articles (NPSP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free